Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA(0),Tyr(3)]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

BACKGROUND: The bone marrow (BM) is a main organ at risk in Lu-177-PSMA-617 therapy of prostate cancer and Lu-177-Octreotate therapy of neuroendocrine tumours. BM dosimetry is challenging and time-consuming, as different sequential quantitative measurements must be combined. The BM absorbed dose fro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Gosewisch, Astrid, Delker, Andreas, Tattenberg, Sebastian, Ilhan, Harun, Todica, Andrei, Brosch, Julia, Vomacka, Lena, Brunegraf, Anika, Gildehaus, Franz Josef, Ziegler, Sibylle, Bartenstein, Peter, Böning, Guido
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081875/
https://ncbi.nlm.nih.gov/pubmed/30076556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0427-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados